CLINICAL NEUROPHARMACOLOGY

Clinical Neuropharmacology (ISSN 0362-5664) is a bi-monthly peer-reviewed journal published in the United States by Lippincott Williams & Wilkins, dedicated to advancing research at the intersection of neuroscience and pharmacology. The journal focuses on clinical neuropharmacological studies, encompassing the mechanisms and therapeutic applications of neuropsychiatric drugs, neurotransmitter dynamics, and pharmacological interventions for neurodegenerative conditions such as Parkinson’s disease and epilepsy. Indexed in the Science Citation Index (SCI), Clinical Neuropharmacology maintains a stable academic profile with an impact factor typically ranging between 2 and 3, placing it within the third or fourth quartile of the Chinese Academy of Sciences (CAS) journal ranking in the fields of medicine and pharmacology. As a non-open access publication, it offers a competitive yet accessible platform for researchers specializing in clinical drug trials and neurobiological mechanisms, providing a reputable venue for disseminating high-quality work in clinical neuropharmacology, although its influence is generally considered moderate compared to top-tier journals in the discipline.